Vitamin C for preventing and treating the common cold
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The role of oral vitamin C (ascorbic acid) in the prevention and treatment of the common cold has been a subject of controversy for at least sixty years. Public interest in the topic continues to be high and vitamin C continues to be widely sold and used as a preventive and therapeutic agent for this common ailment. OBJECTIVES: To discover whether oral vitamin C in doses of 200 mg or more daily, reduces the incidence, duration or severity of the common cold when used either as continuous prophylaxis or after the onset of cold symptoms. SEARCH STRATEGY: This updated review added to earlier searches, a full search of the following electronic databases: the Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 2, 2004); MEDLINE (January 1966 to June 2004); and EMBASE (1990 to June 2004). SELECTION CRITERIA: Papers were excluded if a dose less than 200 mg daily of vitamin C was used; if there was no placebo comparison; if methods of outcome assessment were inadequately described; and if the report did not record any of the three study outcomes (incidence, duration or severity) in sufficient detail to enter into the meta-analysis. Three criteria of study quality were assessed: Jadad scores, placebo distinguish-ability, and allocation concealment. DATA COLLECTION AND ANALYSIS: Two reviewers independently extracted data and assessed trial quality. 'Incidence' of colds during prophylaxis was assessed as the proportion of participants experiencing one or more colds during the study period. 'Duration' was the mean days of illness of cold episodes and 'severity' of these episodes was assessed by days confined indoors, off work or school. or by symptom severity scores. MAIN RESULTS: Twenty-nine trial comparisons involving 11,077 study participants contributed to the meta-analysis on the relative risk (RR) of developing a cold while taking prophylaxis. The pooled RR was 0.96 (95% CI 0.92 to 1.00). A subgroup of six trials that involved a total of 642 marathon runners, skiers, and soldiers on sub-arctic exercises reported a pooled RR of 0.50 (95%CI 0.38 to 0.66). Thirty comparisons that involved 9,676 respiratory episodes contributed to the meta-analysis on common cold duration during prophylaxis . A consistent benefit was observed, representing a reduction in cold duration of 8% (95% CI 3% to 13%) for adult participants and 13.5% (95% CI 5% to 21%) for child participants. Fifteen trial comparisons that involved 7,045 respiratory episodes contributed to the meta-analysis of severity of episodes experienced while on prophylaxis. The pooled results revealed a difference favouring those on vitamin C when days confined to home and off work or school were taken as a measure of severity (p = 0.02), and when restricting to studies which used symptom severity scores (p = 0.16), and for the both measures of severity combined (p = 0.004). Seven trial comparisons that involved 3,294 respiratory episodes contributed to the meta-analysis of cold duration during therapy with vitamin C that was initiated after the onset of cold symptoms, and no significant difference from placebo was seen. Four trial comparisons that involved 2,753 respiratory episodes, contributed to the meta-analysis of cold severity during therapy and no significant difference from placebo was seen.In laboratory studies, differing methods of artificial transmission of virus to vitamin C or placebo treated volunteers in residential experiments gave different results. Volunteers infected by nasal installation showed small or no benefit from vitamin C, whereas a group who were infected more naturally, reported less severe symptom severity scores (p = 0.04). REVIEWERS' CONCLUSIONS: The failure of vitamin C supplementation to reduce the incidence of colds in the normal population indicates that routine mega-dose prophylaxis is not rationally justified for community use. But evidence shows that it could be justified in persons exposed to brief periods of severe physical exercise and/or cold environments. Also, the consistent and statistically significant small benefits on duration and severity for those using regular vitamin C prophylaxis indicates that vitamin C plays some role in respiratory defence mechanisms. The trials in which vitamin C was introduced at the onset of colds as therapy did not show any benefit in doses up to 4 grams daily, but one large trial reported equivocal benefit from an 8 gram therapeutic dose at onset of symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peters, E., Goetzsche, J., Grobbelaar, B., & Noakes, T. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.2.170 · Cited by 280
Effects of ascorbic acid on the common cold
Chalmers, T. C. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90127-8 · Cited by 155
Hemilä, H. (1992) · British Journal Of Nutrition · doi:10.1079/bjn19920004 · Cited by 143
Gorton, H. C., & Jarvis, K. (1999) · Journal of Manipulative and Physiological Therapeutics · doi:10.1016/s0161-4754(99)70005-9 · Cited by 111
Vitamin C prophylaxis in marine recruits
Pitt, H. A. (1979) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1979.03290350028016 · Cited by 103
Kleijnen, J., & Knipschild, P. (1992) · Pharmaceutisch Weekblad Scientific Edition · doi:10.1007/bf01977620 · Cited by 89
Does vitamin C alleviate the symptoms of the common cold? A review of current evidence
Hemilä, H. (1994) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549409008582 · Cited by 88
Self-citationVitamins for the prevention of colds
COWAN, D. W., DIEHL, H. S., & BAKER, A. B. (1942) · Journal of the American Medical Association · doi:10.1001/jama.1942.02830510006002 · Cited by 84
Evaluation of the efficacy of ascorbic acid in prophylaxis of induced rhinovirus 44 infection in man
Schwartz, A. R., Togo, Y., Hornick, R. B., Tominaga, S., & Gleckman, R. A. (1973) · Journal of Infectious Diseases · doi:10.1093/infdis/128.4.500 · Cited by 74
Preventing the common cold with a vitamin C supplement: A double-blind, placebo-controlled survey
Van Straten, M., & Josling, P. (2002) · Advances in Therapy · doi:10.1007/bf02850271 · Cited by 64
Cited by
Guidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
Vitamin C for preventing and treating the common cold
Hemilä, H., & Chalker, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000980.pub4 · Cited by 869
Self-citationGuidelines for the management of adult lower respiratory tract infections - Summary
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03602.x · Cited by 468
Antioxidative and anti-inflammatory activity of ascorbic acid
Gęgotek, A., & Skrzydlewska, E. (2022) · Antioxidants · doi:10.3390/antiox11101993 · Cited by 420
Vitamin C for preventing and treating the common cold
Hemilä, H., Chalker, E., & Douglas, B. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000980.pub3 · Cited by 182
Self-citation
Metadata
- Authors
- Douglas, R., Hemilä, H., Chalker, E., D'Souza, R., & Treacy, B.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2004-10-18
- Issue
- 4
- Pages
- CD000980-CD000980
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4211261507
- Cited by
- 98
- References
- 17
- Type
- reference entry
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vitamin C for preventing and treating the common cold. https://app.cochat.ai/papers/10.1002/14651858.cd000980.pub2
- The paper
- Douglas, R., Hemilä, H., Chalker, E., D'Souza, R., & Treacy, B. (2004). Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd000980.pub2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.